help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, V. J.
Right arrow Articles by Woodruff, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, V. J.
Right arrow Articles by Woodruff, T. K.

Endocrinology, Vol 137, 4201-4209, Copyright © 1996 by Endocrine Society


ARTICLES

Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos

VJ Roberts, CA Bentley, Q Guo, MM Matzuk and TK Woodruff
Department of Reproductive Medicine, University of California, San Diego, La Jolla 92093-0674, USA. vroberts@ucsd.edu

Activin affects the growth and differentiation of many cultured cell types, including rat anterior pituitary cells and gonadal and neuronal cell lines. Endogenous activins regulate mesoderm induction, body axis formation, and organogenisis in the developing embryo. The messenger RNAs encoding inhibin/activin subunits, follistatin (an activin-binding protein), and activin type II receptors (ActRII and IIB) are expressed in various cell types and tissues of the embryonic rat and mouse. Follistatin-deficient mice have numerous embryonic defects, including shiny taut skin, allowing relatively easy identification by the later stages of embryogenesis. ActRII-deficient mice, on the other hand, show limited developmental defects, with some (22%) embryonic day 18.5 (E18.5) ActRII-deficient embryos showing various skeletal and facial abnormalities. The present study was undertaken to identify the target tissues for biologically active activin A and assess the significance of its association with ActRII and follistatin in developing rat and mouse embryos. Fresh-frozen, slide-mounted, rat (E13 to E19) and mouse (E18.5) embryo sections were incubated with 125I-labeled recombinant human activin A. Nonspecific binding was evaluated by competition with an excess of cold activin A. As determined by image analysis, the highest levels of activin A binding were observed throughout the brain, spinal cord, and trigeminal and spinal ganglia at all ages. Lower levels of binding were found in the dermis of the skin starting on E15. Follistatin-deficient mice demonstrated similar patterns and levels of activin A binding in the neural tissues compared to wild-type controls, but binding was absent in the skin. In ActRII-deficient mice, activin A binding was completely absent in neural tissues, but was similar to wild-type control levels in the dermal layer of the skin. The data indicate that activin A binds to specific tissues of mouse and rat embryos and that binding is dependent upon the presence of ActRII in the central and peripheral nervous system and on follistatin in the skin.


This article has been cited by other articles:


Home page
ReproductionHome page
R. L Jones, T. J Kaitu'u-Lino, G. Nie, L G. Sanchez-Partida, J. K Findlay, and L. A Salamonsen
Complex expression patterns support potential roles for maternally derived activins in the establishment of pregnancy in mouse.
Reproduction, November 1, 2006; 132(5): 799 - 810.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Debieve, L. Hinck, J.-M. Biard, P. Bernard, and C. Hubinont
Activin receptor expression and induction of apoptosis in rat blastocysts in vitro
Hum. Reprod., March 1, 2006; 21(3): 618 - 623.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. B. Draper, M. M. Matzuk, V. J. Roberts, E. Cox, J. Weiss, J. P. Mather, and T. K. Woodruff
Identification of an Inhibin Receptor in Gonadal Tumors from Inhibin alpha -Subunit Knockout Mice
J. Biol. Chem., January 2, 1998; 273(1): 398 - 403.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Q. Guo, T. R. Kumar, T. Woodruff, L. A. Hadsell, F. J. DeMayo, and M. M. Matzuk
Overexpression of Mouse Follistatin Causes Reproductive Defects in Transgenic Mice
Mol. Endocrinol., January 1, 1998; 12(1): 96 - 106.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Esparza-Lopez, J. L. Montiel, M. M. Vilchis-Landeros, T. Okadome, K. Miyazono, and F. Lopez-Casillas
Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-beta Superfamily. SPECIALIZED BINDING REGIONS FOR TRANSFORMING GROWTH FACTOR-beta AND INHIBIN A
J. Biol. Chem., April 27, 2001; 276(18): 14588 - 14596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society